Angelman Gene Therapy Trial Paused

Nov 06, 2020

A clinical trial of a gene therapy for Angelman syndrome is on hold, Spectrum reports. It adds that two participants experienced an adverse effect that affected their ability to walk.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Another Study for AstraZeneca

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna to Seek EUA

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

To Spot it Earlier

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

PLOS Papers on Glioblastoma in Lebanon, Syndromic Gene PheWAS, Newborn Cytokine GWAS

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.

Menu